A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2006
12/28/2006	WO2006138670A2 Antibody complexes
12/28/2006	WO2006138038A1 Intralesional treatment of psoriasis
12/28/2006	WO2006137658A1 New substituted 1,3-thiazole derivatives or pharmaceutically acceptable salts thereof having immunosuppression and inflammation inhibitory acitivity, intermediate compounds or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical composition comprising the same
12/28/2006	WO2006137513A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006	WO2006137509A1 Cyclic amine derivative containing ppar regulator
12/28/2006	WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof
12/28/2006	WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller
12/28/2006	WO2006137433A1 Aqueous preparation having levocabastine solubilized therein
12/28/2006	WO2006137421A1 Agent for topical administration
12/28/2006	WO2006137060A1 Immune disease medicament comprising a modulator of the binding between a heparin binding domain of thrombospondin-1 and a beta1 integrin
12/28/2006	WO2006137019A1 Novel thiophene derivatives
12/28/2006	WO2006136830A1 Aryl-alkylamines and heteroaryl-alkylamines as protein kinase inhibitors
12/28/2006	WO2006135993A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
12/28/2006	WO2006108670A3 Use of cd25 antibodies in immunotherapy
12/28/2006	WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006	WO2006089251A3 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS
12/28/2006	WO2006024958A3 Cannabinoid compositions and methods of use thereof
12/28/2006	WO2006010054A3 Multivalent vla-4 antagonists comprising polyethylene glycol moieties
12/28/2006	WO2006000923A3 Macrolide compositions as therapeutic agent
12/28/2006	WO2005079423A3 Chemically programmable immunity
12/28/2006	WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies
12/28/2006	US20060293507 Crystallization of IGF-1
12/28/2006	US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/28/2006	US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases
12/28/2006	US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/28/2006	US20060293347 Pharmaceutically active compounds
12/28/2006	US20060293337 P2x7 receptor antagonists and their use
12/28/2006	US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006	US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006	US20060293297 Cyanofluoropyrrolidine derviative
12/28/2006	US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3
12/28/2006	US20060293263 Preparation for preventing contact of pathogenic matter with living organism
12/28/2006	US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics
12/28/2006	US20060293219 Methods of treating diabetes mellitus
12/28/2006	US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases
12/28/2006	US20060292644 Novel tumor-associated marker
12/28/2006	US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006	US20060292145 Human antihuman interleukin-18 antibody, fragment thereof and method for using same
12/28/2006	US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin
12/28/2006	US20060292133 Use of lactobacillus salivarius
12/28/2006	US20060292131 Chondrocyte Therapeutic Delivery System
12/28/2006	US20060292118 Hollow nanoparticles of protein and drug using the same
12/28/2006	US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
12/28/2006	US20060292115 Methods and compositions for treating and preventing inflammatory conditions
12/28/2006	US20060289834 External composition containing Unsaturated fatty acid or its salt or ester
12/28/2006	CA2836319A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
12/28/2006	CA2809723A1 Treatment of autoimmune disorders with a neurotoxin
12/28/2006	CA2633030A1 Intralesional treatment of psoriasis
12/28/2006	CA2614111A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006	CA2613253A1 Combination comprising amino alcohol derivatives as immunosuppressants
12/28/2006	CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof
12/28/2006	CA2612788A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c
12/28/2006	CA2612661A1 Novel thiophene derivatives
12/28/2006	CA2612355A1 Antibody complexes
12/27/2006	EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736545A2 Soluble zcytor 11 cytokine receptors
12/27/2006	EP1736541A1 Novel galectin 9 modification protein and use thereof
12/27/2006	EP1736479A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
12/27/2006	EP1736472A1 2-aminopyridine derivative
12/27/2006	EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators
12/27/2006	EP1736170A2 Agent for treating allergic or hypersensitivity condition
12/27/2006	EP1736161A2 Use of an arsenic compound for the manufacture of a medicament for the treatment of arsenic susceptible blast-like cell related diseases
12/27/2006	EP1735277A1 2-alkylidene-18,19-dinor-vitamin d compounds
12/27/2006	EP1734975A1 Herbal therapy for the treatment of food allergy
12/27/2006	EP1734967A2 Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
12/27/2006	EP1734952A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
12/27/2006	EP1734946A2 Method of using punicic acid to enhance immune response and prevent metabolic disorders
12/27/2006	EP1660476B1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives
12/27/2006	EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
12/27/2006	EP1480961B1 Glutaminyl based dpiv inhibitors
12/27/2006	EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/27/2006	EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/27/2006	EP1368317B1 Tryptase inhibitors
12/27/2006	EP1358209B1 Crystallization of igf-1
12/27/2006	EP1354047B1 Methods for screening compounds that modulate lipid metabolism
12/27/2006	EP1339422B1 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
12/27/2006	EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
12/27/2006	EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006	EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection
12/27/2006	EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
12/27/2006	EP1185618B1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/27/2006	EP1183367B1 Cytotoxic t-cell epitope of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/27/2006	EP1105505B1 Compound and method for the prevention and/or the treatment of allergy
12/27/2006	EP1073739B1 Cd40-interacting and traf-interacting proteins
12/27/2006	CN1886511A Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus
12/27/2006	CN1886506A Protein expressed in nk cell
12/27/2006	CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006	CN1886375A Piperidine compound and method for producing same
12/27/2006	CN1886156A Immunotherapy method
12/27/2006	CN1884479A Anti AIDS 1 type virus compound preparation method
12/27/2006	CN1883676A Preparation for treating rhinitis
12/27/2006	CN1883668A Dry concentrate of yellow wine and preparation method thereof
12/27/2006	CN1883655A Oral liquid with astragali and king solomonseal rhizome and preparation method thereof
12/27/2006	CN1883650A Health-caring essence and preparation method thereof
12/27/2006	CN1883605A Vinegar capable of improving cerebral function
12/27/2006	CN1883590A Method for preparing ganoderma spore oil
12/27/2006	CN1883540A A lyophilized injection of pharmaceutical composition and method for preparing same
12/27/2006	CN1883538A A nano Aidi injection preparation and method for preparing same
12/27/2006	CN1883528A Chinese medicine extracts for improving immunity and treating human and animal influenza

1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 1172